The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists will Gather for the 2023 Tandem Meetings to Improve the Lives of Patients with Blood-Related Disorders and Solid Tumors.
Read Press ReleaseIn response to a call for tenders, Tribun Health had to undergo numerous evaluations and a rating system before joining the UniHA network in digital pathology.
Read Press ReleaseVirtual workshop on Nov. 17-18 bridges the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.
Read Press ReleaseGerman-based biotechnology company BioNTech will establish a clinical scale research mRNA manufacturing facility in Australia, following an in-principle letter of intent signed with the Victorian Government.
Read Press ReleaseMindpeak breast cancer algorithms have been seamlessly integrated into the gold-standard image management software, CaloPix 5, enhancing the pathologist's possibilities.
Read Press ReleaseAmerican Society for Transplantation and Cellular Therapy (ASTCT) is pleased to announce that Owhofasa Agbedia, MD, MPH, has been selected by the American Society of Hematology (ASH), the Center of International Blood and Marrow Transplant Research (CIBMTR), and ASTCT to receive the ASH-CIBMTR-ASTCT Career Development Award.
Read Press ReleaseAmerican Society for Transplantation and Cellular Therapy (ASTCT) presented top awards to leaders in the field of transplantation and cellular therapy at the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
Read Press ReleaseThe Addition of NJHOA's 4-Provider, 3-Location Practice Brings QCCA's Membership to 482 Oncology Practitioners in 17 Practices at 126 Locations Across the Country
Read Press ReleaseA PNAS study demonstrates platelet-derived growth factor D (PDGF-D) binding to PDGF receptor-beta (PDGFRβ) activates NK cells to enhance interleukin (IL)-15-mediated NK cell survival.
City of Hope research suggests that the selective introduction of PDGF signaling in NK cells by IL-15 should benefit NK cell expansion and persistence and/or enhance effector function in NK cell-based immunotherapies.
The clinical-stage biotech CytoImmune Therapeutics welcomes Puerto Rico native and biochemistry and molecular biology expert José Eduardo Vidal, Ph.D., to lead the cellular and virus manufacturing capabilities.
Read Press ReleaseThree-dimensional microscale hanging drop arrays are useful in drug discovery, regenerative medicine, stem cell research, and biotechnology.
Read Press Release